autosomal dominant polycystic kidney disease
Showing 1 - 25 of 46
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023
Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases Trial in New Taipei City, Taipei (Atorvastatin 20 Mg Oral
Enrolling by invitation
- Autosomal Dominant Polycystic Kidney Disease
- Chronic Kidney Diseases
- Atorvastatin 20 Mg Oral Tablet
- Sodium Bicarbonate 600 Mg Oral Tablet
-
New Taipei City, Taiwan
- +2 more
May 19, 2023
Autosomal Dominant Polycystic Kidney Disease Trial in Australia (Metformin XR, Control)
Not yet recruiting
- Autosomal Dominant Polycystic Kidney Disease
- Metformin XR
- Control
-
Sydney, New South Wales, Australia
- +3 more
Nov 9, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Rochester
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
Intrarenal Microvasculature in ADPKD
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 15, 2022
Endothelial Function and Oxidative Stress in Normotensive ADPKD
Completed
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
Uncontrolled Hypertension, Autosomal Dominant Polycystic Kidney Disease, Renal Denervation Trial in Erlangen (Renal denervation)
Recruiting
- Uncontrolled Hypertension
- +2 more
- Renal denervation
-
Erlangen, GermanyUniversity Hospital FAU Erlangen-Nürnberg
Jul 11, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Ranica (Tolvaptan, Octreotide LAR, Placebo)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan
- +2 more
-
Ranica, Bergamo, ItalyCRC per le Malattie Rare Aldo e Cele Daccò
Mar 10, 2022
Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus Trial in
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
- +3 more
-
Rochester, MinnesotaMayo Clinic Rochester
Feb 14, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Los Angeles (Pravastatin, sodium citrate)
Enrolling by invitation
- Autosomal Dominant Polycystic Kidney Disease
- Pravastatin
- sodium citrate
-
Los Angeles, CaliforniaKeck School of Medicine of University of Southern California
Jan 24, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Worldwide (Placebo, GLPG2737)
Active, not recruiting
- Autosomal Dominant Polycystic Kidney Disease
- Placebo
- GLPG2737
-
Brussels, Belgium
- +19 more
Nov 23, 2021
Autosomal Dominant Polycystic Kidney Disease Trial in New York
Active, not recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
New York, New YorkWeill Cornell Medicine
Jul 29, 2021
Autosomal Dominant Polycystic Kidney Disease Trial in United States (Lixivaptan)
Completed
- Autosomal Dominant Polycystic Kidney Disease
-
Los Angeles, California
- +12 more
Nov 25, 2020
Autosomal Dominant Polycystic Kidney Disease Trial in Mitaka (Tolvaptan)
Unknown status
- Autosomal Dominant Polycystic Kidney Disease
-
Mitaka, Tokyo, JapanKyorin University Hospital
Jun 3, 2020
Somatostatin Analogs, Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Disease Trial in Rochester (Pasireotide
Completed
- Somatostatin Analogs
- +3 more
- Pasireotide LAR
- Placebo
-
Rochester, MinnesotaMayo Clinic
Apr 30, 2020
ADPKD Alterations in Hepatic Transporter Function
Completed
- ADPKD
- +2 more
-
Chapel Hill, North CarolinaUniversity of North Carolina
Mar 23, 2020
ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Intra-peritoneal pressure
-
Reims, FranceDamien JOLLY
May 29, 2019
Quality of Life, Treatment Preference and Satisfaction of ADPKD
Unknown status
- Autosomal Dominant Polycystic Kidney Disease
-
Vienna, Austria
- +25 more
Apr 9, 2019
Autosomal Dominant Polycystic Kidney Disease Trial (Vessix)
Withdrawn
- Autosomal Dominant Polycystic Kidney Disease
- Vessix
- (no location specified)
Apr 1, 2019
Autosomal Dominant Polycystic Kidney Disease Trial in Groningen (Tolvaptan)
Completed
- Autosomal Dominant Polycystic Kidney Disease
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 20, 2019
Autosomal Dominant Polycystic Kidney Disease Trial in Cambridge (High water intake, Ad libitum water intake)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- High water intake
- Ad libitum water intake
-
Cambridge, United KingdomCambridge University Hospitals NHS Foundation Trust
Jan 13, 2019
Autosomal Dominant Polycystic Kidney Disease Trial in Le Kremlin-Bicêtre (Everolimus, Calcineurin inhibitors maintenance)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Everolimus
- Calcineurin inhibitors maintenance
-
Le Kremlin-Bicêtre, FranceBicêtre Hospital
Dec 7, 2018
Autosomal Dominant Polycystic Kidney Disease Trial in United States (Tolvaptan MR, Tolvaptan IR, Placebo)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Tolvaptan MR
- +2 more
-
Huntsville, Alabama
- +34 more
Aug 30, 2018
Autosomal Dominant Polycystic Kidney Disease Trial in Kanto Region (OPC-41061)
Completed
- Autosomal Dominant Polycystic Kidney Disease
-
Kanto Region, Japan(unnamed)
Aug 15, 2018